Xiang Long

2.0k total citations
46 papers, 1.3k citations indexed

About

Xiang Long is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiang Long has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Cancer Research and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiang Long's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and RNA modifications and cancer (7 papers). Xiang Long is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers) and RNA modifications and cancer (7 papers). Xiang Long collaborates with scholars based in China, Hong Kong and United States. Xiang Long's co-authors include Shu‐Qiang Zhu, Yongbing Wu, Jianjun Xu, Bai‐Quan Qiu, Xu Pei, Dian Xiong, Feng Lü, Kun Lin, Shiwei Chen and Tony Mok and has published in prestigious journals such as Cancer, Biochemical and Biophysical Research Communications and Life Sciences.

In The Last Decade

Xiang Long

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiang Long China 18 983 660 263 193 187 46 1.3k
Yaguang Weng China 25 924 0.9× 549 0.8× 276 1.0× 166 0.9× 101 0.5× 53 1.4k
Shu‐Biao Wu China 23 841 0.9× 457 0.7× 294 1.1× 146 0.8× 131 0.7× 55 1.2k
Meryem Gülfem Öner Germany 7 816 0.8× 766 1.2× 296 1.1× 188 1.0× 75 0.4× 7 1.3k
Jian Zhou China 22 858 0.9× 636 1.0× 367 1.4× 142 0.7× 234 1.3× 95 1.4k
Ming Zhong China 20 838 0.9× 571 0.9× 382 1.5× 187 1.0× 104 0.6× 56 1.4k
Dandan Wang China 21 1000 1.0× 812 1.2× 173 0.7× 140 0.7× 115 0.6× 52 1.3k
Qi-Shan Dai China 21 770 0.8× 426 0.6× 289 1.1× 119 0.6× 291 1.6× 39 1.2k

Countries citing papers authored by Xiang Long

Since Specialization
Citations

This map shows the geographic impact of Xiang Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Long more than expected).

Fields of papers citing papers by Xiang Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Long. The network helps show where Xiang Long may publish in the future.

Co-authorship network of co-authors of Xiang Long

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang Long. A scholar is included among the top collaborators of Xiang Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang Long. Xiang Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Long, Xiang, et al.. (2025). Dimensionally stable thermal-stiffening composite hydrogels enabled by thermo-responsive SiO2 hybrid nanoparticles. Colloids and Surfaces A Physicochemical and Engineering Aspects. 709. 136129–136129. 2 indexed citations
4.
Gao, Jian, Xiang Long, Pengfei Zhang, et al.. (2022). The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis. Molecular Cancer. 21(1). 110–110. 88 indexed citations
5.
Qiu, Bai‐Quan, Xiahui Lin, Songqing Lai, et al.. (2021). ITGB1-DT/ARNTL2 axis may be a novel biomarker in lung adenocarcinoma: a bioinformatics analysis and experimental validation. Cancer Cell International. 21(1). 665–665. 14 indexed citations
6.
Lü, Feng, Shu‐Qiang Zhu, Xiang Long, et al.. (2021). Clinical study of minimally invasive aortic valve replacement through a right parasternal second intercostal transverse incision: The first Chinese experience. Asian Journal of Surgery. 44(8). 1063–1068. 8 indexed citations
7.
Long, Xiang, et al.. (2021). Clinical benefit of COX-2 inhibitors in the adjuvant chemotherapy of advanced non-small cell lung cancer: A systematic review and meta-analysis. World Journal of Clinical Cases. 9(3). 581–601. 4 indexed citations
8.
Ye, Xudong, Bai‐Quan Qiu, Dian Xiong, et al.. (2020). High level of H3K4 tri-methylation modification predicts poor prognosis in esophageal cancer. Journal of Cancer. 11(11). 3256–3263. 4 indexed citations
9.
Tu, Li, et al.. (2019). <p>MiR-34c acts as a tumor suppressor in non-small cell lung cancer by inducing endoplasmic reticulum stress through targeting HMGB1</p>. OncoTargets and Therapy. Volume 12. 5729–5739. 22 indexed citations
10.
Qiu, Bai‐Quan, Pengfei Zhang, Dian Xiong, et al.. (2018). CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non‐small cell lung cancer by regulating Galectin‐1‐AKT/ERK1/2 signaling. Journal of Cellular Physiology. 234(7). 11256–11264. 66 indexed citations
11.
Wang, Ling, Lin Ye, Yu Chen, et al.. (2018). Conditional reprogrammed human limbal epithelial cells represent a novel in vitro cell model for drug responses. Biochemical and Biophysical Research Communications. 499(4). 735–742. 11 indexed citations
12.
Zhang, Zhengbao, Qing Bai, Yu Chen, et al.. (2018). Conditionally reprogrammed human normal bronchial epithelial cells express comparable levels of cytochromes p450 and are sensitive to BaP induction. Biochemical and Biophysical Research Communications. 503(3). 2132–2138. 16 indexed citations
13.
Xiong, Dian, Shu‐Qiang Zhu, Yongbing Wu, et al.. (2018). Ring finger protein 38 promote non-small cell lung cancer progression by endowing cell EMT phenotype. Journal of Cancer. 9(5). 841–850. 18 indexed citations
14.
Liao, Yunfei, et al.. (2017). Minimally access via left anterior mini-thoracotomy for repair of adult subarterial ventricular septal defects. Journal of Cardiothoracic Surgery. 12(1). 48–48. 5 indexed citations
15.
Yang, Shucai, Yi Liu, Mingyue Li, et al.. (2017). FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer. Molecular Cancer. 16(1). 124–124. 328 indexed citations
16.
Liu, Yi, Zhili Zhao, Bin Wu, et al.. (2015). Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1. Journal of Molecular Medicine. 93(11). 1221–1233. 12 indexed citations
18.
Ng, Calvin S.H., Innes Y.P. Wan, Jing Du, et al.. (2013). Thromboxane A2 receptor α promotes tumor growth through an autoregulatory feedback pathway. Journal of Molecular Cell Biology. 5(6). 380–390. 21 indexed citations
19.
Yan, Hao, et al.. (2012). D2 dopamine receptor antagonist raclopride induces non‐canonical autophagy in cardiac myocytes. Journal of Cellular Biochemistry. 114(1). 103–110. 24 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026